Showing 1 to 1 of 1 results
pt.euronews.com
🌐 85% Global Worthiness


EMA Conditionally Approves Alzheimer's Drug Donanemab Under Strict Safety Protocols
The European Medicines Agency (EMA) conditionally approved the Alzheimer's drug donanemab (Kisunla) for patients with one or zero copies of a gene linked to increased risk, after initially rejecting it due to the risk of brain swelling and bleeding; the drug will be available only under strict safet...
EMA Conditionally Approves Alzheimer's Drug Donanemab Under Strict Safety Protocols
The European Medicines Agency (EMA) conditionally approved the Alzheimer's drug donanemab (Kisunla) for patients with one or zero copies of a gene linked to increased risk, after initially rejecting it due to the risk of brain swelling and bleeding; the drug will be available only under strict safet...
Progress
32% Bias Score
Good Health and Well-being
Showing 1 to 1 of 1 results